Related Experiment Videos
Is high-dose radioimmunotherapy needed in non-Hodgkin's lymphoma? For
1Department of Nuclear Medicine of the Philipps-University of Marburg, Baldingerstrasse, 35043 Malburg, Germany. tmbehr@mailer.uni-marburg.de
European Journal of Nuclear Medicine and Molecular Imaging
|November 7, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Scintigraphic assessment of salivary gland function in a rat model.
In vivo (Athens, Greece)·2010
Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Molecular pharmaceutics·2009
Effective treatment of pancreatic neuroendocrine tumours transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
European journal of nuclear medicine and molecular imaging·2009
Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
Nuclear medicine communications·2008
Imaging of gastrinomas by nuclear medicine methods.
Wiener klinische Wochenschrift·2007
Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
European journal of nuclear medicine and molecular imaging·2006
Prognostic value and diagnostic performance of nectin-4-targeted [68Ga]Ga-FZ-NR-1 PET/CT versus [18F]FDG in recurrent or metastatic triple-negative breast cancer.
European journal of nuclear medicine and molecular imaging·2026
Practices and barriers in PET/CT use for critically ill patients: an international survey.
European journal of nuclear medicine and molecular imaging·2026
Radium-223 decreases PD-L1 expression in bone metastases: A study with [89Zr]Zr-atezolizumab PET and immunohistological correlation.
European journal of nuclear medicine and molecular imaging·2026
Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.
European journal of nuclear medicine and molecular imaging·2026
APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer's disease spectrum: A retrospective observational study.
European journal of nuclear medicine and molecular imaging·2026
Patient selection for primary staging with [99mTc]Tc-PSMA SPECT/CT: influence of combined PSA and ISUP grade on detection of metastatic disease.
European journal of nuclear medicine and molecular imaging·2026
The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.
Immunologic research·2026
Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.
Archives of pathology & laboratory medicine·2026
Spatial statistics infer structured immune signatures in primary prostate cancer.
Cancer immunology research·2026